Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Ito

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 7, 2012
Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trialHiroshi Takahashi, Masashi Yamazaki, Akihiko Okawa, et al.
Spine|December 5, 2013
Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 yearTaigo Inada, Hiroshi Takahashi, Masashi Yamazaki, et al.
BMJ Open|May 7, 2018
Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injuryMasao Koda, Hideki Hanaoka, Takatoshi Sato, et al.
Brain : a Journal of Neurology|March 25, 2021
Randomized trial of granulocyte colony-stimulating factor for spinal cord injuryMasao Koda, Hideki Hanaoka, Yasuhisa Fujii, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 7, 2012
Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trialHiroshi Takahashi, Masashi Yamazaki, Akihiko Okawa, et al.
Spine|December 5, 2013
Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 yearTaigo Inada, Hiroshi Takahashi, Masashi Yamazaki, et al.
BMJ Open|May 7, 2018
Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injuryMasao Koda, Hideki Hanaoka, Takatoshi Sato, et al.
Brain : a Journal of Neurology|March 25, 2021
Randomized trial of granulocyte colony-stimulating factor for spinal cord injuryMasao Koda, Hideki Hanaoka, Yasuhisa Fujii, et al.
Pageof 9